Home > Compound List > Product Information
PD318088_Molecular_structure_CAS_391210-00-7)
Click picture or here to close

PD318088

Catalog No. S1568 Name Selleck Chemicals
CAS Number 391210-00-7 Website http://www.selleckchem.com
M. F. C16H13BrF3IN2O4 Telephone (877) 796-6397
M. W. 561.0890996 Fax (832) 582-8590
Purity Email sales@selleckchem.com
Storage -20°C Chembase ID: 72748

SYNONYMS

IUPAC name
5-bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
IUPAC Traditional name
C16H13BrF3IN2O4

DATABASE IDS

CAS Number 391210-00-7

PROPERTIES

Target MEK
Salt Data Free Base
Storage Condition -20°C

DETAILS

Description (English)
Research Area
Description Cancer
Biological Activity
Description PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor.
Targets MEK1/2
IC50
In Vitro PD318088 is a small-molecule inhibitor of MEK1/2, which is an analog of PD184352, suggesting it might have substantial anti-proliferative activity against cancer cells, although no functional study of PD318088 is currently available. PD318088 binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site. Formation of the ternary complexes with PD318088 and MgATP results in moderate increases (to 140 nM) for the Kd monomer-dimer for both MEK1 and MEK2. The binding of PD318088 and MgATP to MEK1 also abolishes the formation of tetramers and higher-order aggregates. PD318088 and MgATP together increase the dimerization disassociation constant for MEK1 and MEK2 slightly from ~75 nM to ~140 nM, suggesting that the mechanism of inhibition for PD318088 is probably a result of localized conformational changes in the active site and not a global change in the overall structure. [1]
In Vivo
Clinical Trials
Features
References
[1] Ohren JF, et al. Nat Struct Mol Biol, 2004, 11(12), 1192-1197.